Assessment of HLADP gene rs3128917 and rs9380343 polymorphisms in chronic HBV infection

Ersin Akgöllü1

  • 1Department of Gastroenterology, Çukurova University School of Medicine, Adana, Turkey.

Insights

The human leukocyte antigen (HLA) rs9380343 gene variant is linked to persistent Hepatitis B virus (HBV) infection. This genetic factor increases the risk of chronic HBV, particularly in males.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Viral Hepatitis Research

Background:

  • Hepatitis B virus (HBV) infection affects 400 million globally, with 10-15% of carriers developing severe liver disease.
  • Genetic factors, including human leukocyte antigen (HLA) variants, influence HBV infection chronicity.
  • Previous genome-wide association studies identified HLA variants rs3128917 and rs9380343 associated with persistent HBV.

Purpose of the Study:

  • To investigate the association between specific HLA gene variants and the chronicity of HBV infection.
  • To determine if HLA rs3128917 and rs9380343 polymorphisms influence the risk of persistent HBV infection.

Main Methods:

  • A case-control study was conducted involving 238 chronic HBV patients and 238 individuals with spontaneous HBV clearance.
  • Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was used to analyze HLA variants.

Main Results:

  • The rs9380343 polymorphism (both allele and genotype) showed a significant association with persistent HBV infection (p=0.038 and p=0.029, respectively).
  • The rs3128917 polymorphism did not show a significant association with persistent HBV infection.
  • rs9380343 polymorphism was also linked to an increased risk of HBV infection in males (p<0.05).

Conclusions:

  • The HLA rs9380343 polymorphism is identified as a genetic risk factor for the chronicity of HBV infection.
  • This study provides the first evidence linking HLA rs9380343 to persistent HBV infection.
  • Further validation with larger sample sizes and diverse populations is recommended to confirm these findings.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
682
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
156
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
37.6K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
11.4K